PMID- 25195871 OWN - NLM STAT- MEDLINE DCOM- 20150723 LR - 20141117 IS - 1460-9568 (Electronic) IS - 0953-816X (Linking) VI - 40 IP - 10 DP - 2014 Nov TI - Altered synaptic transmission at olfactory and vomeronasal nerve terminals in mice lacking N-type calcium channel Cav2.2. PG - 3422-35 LID - 10.1111/ejn.12713 [doi] AB - We investigated the role of voltage-activated calcium (Cav) channels for synaptic transmission at mouse olfactory and vomeronasal nerve terminals at the first synapse of the main and accessory olfactory pathways, respectively. We provided evidence for a central role of the N-type Cav channel subunit Cav2.2 in presynaptic transmitter release at these synapses. Striking Cav2.2 immunoreactivity was localised to the glomerular neuropil of the main olfactory bulb (MOB) and accessory olfactory bulb (AOB), and co-localised with presynaptic molecules such as bassoon. Voltage-clamp recordings of sensory nerve-evoked, excitatory postsynaptic currents (EPSCs) in mitral/tufted (M/T) and superficial tufted cells of the MOB and mitral cells of the AOB, in combination with established subtype-specific Cav channel toxins, indicated a predominant role of N-type channels in transmitter release at these synapses, whereas L-type, P/Q-type, and R-type channels had either no or only relatively minor contributions. In Cacna1b mutant mice lacking the Cav2.2 (alpha1B) subunit of N-type channels, olfactory nerve-evoked M/T cell EPSCs were not reduced but became blocker-resistant, thus indicating a major reorganisation and compensation of Cav channel subunits as a result of the Cav2.2 deletion at this synapse. Cav2.2-deficient mice also revealed that Cav2.2 was critically required for paired-pulse depression of olfactory nerve-evoked EPSCs in M/T cells of the MOB, and they demonstrated an essential requirement for Cav2.2 in vomeronasal nerve-evoked EPSCs of AOB mitral cells. Thus, Cacna1b loss-of-function mutations are unlikely to cause general anosmia but Cacna1b emerges as a strong candidate in the search for mutations causing altered olfactory perception, such as changes in general olfactory sensitivity and altered social responses to chemostimuli. CI - (c) 2014 Federation of European Neuroscience Societies and John Wiley & Sons Ltd. FAU - Weiss, Jan AU - Weiss J AD - Department of Physiology, University of Saarland School of Medicine, Kirrbergerstrasse, Building 58, D-66421, Homburg, Germany. FAU - Pyrski, Martina AU - Pyrski M FAU - Weissgerber, Petra AU - Weissgerber P FAU - Zufall, Frank AU - Zufall F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140905 PL - France TA - Eur J Neurosci JT - The European journal of neuroscience JID - 8918110 RN - 0 (Bsn protein, mouse) RN - 0 (Cacna1b protein, mouse) RN - 0 (Calcium Channel Blockers) RN - 0 (Calcium Channels, L-Type) RN - 0 (Calcium Channels, N-Type) RN - 0 (Nerve Tissue Proteins) RN - 0 (Olfactory Marker Protein) RN - 0 (Omp protein, mouse) RN - 0 (Slc17a6 protein, mouse) RN - 0 (Vesicular Glutamate Transport Protein 2) RN - EC 1.14.16.2 (Tyrosine 3-Monooxygenase) SB - IM MH - Animals MH - Calcium Channel Blockers/pharmacology MH - Calcium Channels, L-Type/metabolism MH - Calcium Channels, N-Type/genetics/*metabolism MH - Excitatory Postsynaptic Potentials/drug effects/physiology MH - Female MH - Male MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Mutation MH - Nerve Tissue Proteins/metabolism MH - Olfactory Bulb/drug effects/*physiology MH - Olfactory Marker Protein/metabolism MH - Olfactory Nerve/drug effects/physiology MH - Patch-Clamp Techniques MH - Presynaptic Terminals/drug effects/physiology MH - Synaptic Transmission/drug effects/*physiology MH - Tissue Culture Techniques MH - Tyrosine 3-Monooxygenase/metabolism MH - Vesicular Glutamate Transport Protein 2/metabolism MH - Vomeronasal Organ/drug effects/innervation/*physiology OTO - NOTNLM OT - Cacna1b OT - aggression OT - channelopathy OT - olfactory plasticity OT - omega-conotoxin GVIA EDAT- 2014/09/10 06:00 MHDA- 2015/07/24 06:00 CRDT- 2014/09/09 06:00 PHST- 2014/05/13 00:00 [received] PHST- 2014/07/31 00:00 [revised] PHST- 2014/08/04 00:00 [accepted] PHST- 2014/09/09 06:00 [entrez] PHST- 2014/09/10 06:00 [pubmed] PHST- 2015/07/24 06:00 [medline] AID - 10.1111/ejn.12713 [doi] PST - ppublish SO - Eur J Neurosci. 2014 Nov;40(10):3422-35. doi: 10.1111/ejn.12713. Epub 2014 Sep 5.